To better support pharmaceutical companies, biotech firms, and medical device manufacturers in Australia, AX for Pharma will be expanding its presence in the region with an office in Sydney.
“With its wide range of startups, mature companies, and mergers and acquisitions, Australia is a promising market for us,” says Andrea Ruosi, CEO and Founder of AX for Pharma. “Life sciences companies in the region have a tremendous need for a flexible, powerful, and affordable ERP solution and are seeking to extend their Microsoft Dynamics 365 footprint.”
As a Microsoft Gold Partner, AX for Pharma offers a very comprehensive end-to-end life sciences ERP solution, native to Microsoft Dynamics 365. “We’re looking forward to working more closely with Microsoft Australia to help life sciences organizations stay nimble and competitive,” Mr. Ruosi says.
According to Forrester, companies that deploy Microsoft Dynamics 365 typically recoup their investment in as little as six months, through reduced infrastructure costs and automated processes.
What makes the AX for Pharma 365™ solution especially attractive to life sciences companies is that it accommodates their unique needs without expensive and time-consuming customizations.
“Life sciences companies in Australia must comply with data residency laws and regulations put forward by the nation’s Therapeutic Goods Administration (TGA),” says Mr. Ruosi. “Our solution relieves much of this burden right out of the box.”
To contact AX for Pharma in Australia, email [email protected].
